​

There is a clinical need for continuous monitoring of vital molecular biomarkers and drug concentrations. However, with the exception of venous oxygen and glucose, these concentrations are currently determined via lab tests. Lab testing costs valuable time, which is relevant for transient biomarkers and critically sick patients. Additionally, lab testing is intermittent at best, and requires infrastructure, reagents, and skilled operators, which aren’t always available in remote locations.

Electrochemical aptamer-based (EAB) sensors, invented and developed by Prof. Kevin Plaxco at the University of California, Santa Barbara, can be adapted for multiple molecular targets, are reagent-free, and work in-vivo, thus enabling on-body wearable devices. Nutromics is integrating the EAB technology into a wearable ‘lab on the skin’ to meet the pressing clinical need of monitoring molecular biomarkers and drugs.

In this presentation I will discuss the EAB sensor technology, how it compares with continuous glucose monitors, the advantages and limitations of the technology, and finally, the potential of Continuous Molecular Monitoring (CMM) wearable devices using EAB sensors.

Simple RGB video of the human face gives away physiological information through tiny changes in skin color and motion — imperceptible to the human eye, but measurable by the computer to produce estimates of vital signs such as heart rate and respiration rate. The technology that accomplishes this is know as remote photoplethysmography (rPPG), highlighting its major advantage of not requiring physical contact between subject and sensor.

First proposed in 2008, rPPG has yet to be widely commercialized. This is in part due to the difficulty in obtaining reliable measurements in challenging real-world conditions, especially regarding illumination conditions and subject movement. This talk will (i) introduce the basis for the signals obtained with camera sensors, (ii) walk through the technological improvements made by researchers since 2008, and (iii) summarize current issues and give an outlook on future applications.

Current wearable sensor technologies provide limited and less reliable health parameters based mainly on heart rate measurement. Any reliable cardiovascular health assessment requires blood pressure measurements. Many attempts had been made to provide blood pressure measurements using commercially available wearable sensors like in smart watches. However, all attempts failed in measuring blood pressure as required by medical standards. On the other hand, FDA cleared Cardiex\AtCor medical technology became the ‘gold standard’ in measuring non-invasively heart and arterial pressure parameters reflecting cardiac and arterial health.
The challenge is to adapt such medical technology into the wearable sensor devices. This involves examining different and new sensors. It also involve new methods of sensor signals based on cardiovascular physiology to extract clinically significant central arterial pressure parameters. This presentation will review current health wearable technologies, challenges in providing reliable cardiovascular health assessment, and Cardiex current development of medical wearable devices to provide clinical heart and arterial health assessments.

This talk will illustrate possibilities for the field of e-textiles by warp knitted products.
Already today highly functional products in the fields of active & sportswear, lingerie, outerwear, automotive and agricultural fabrics are based on warp knitted materials.
During this highly productive production process fabrics can be functionalized, therefore warp knitted fabrics will enrich the chances of e-textiles and change the market.
In this presentation you will see different functional systems done by this technology including a coil for inductive charging and a sensor shirt to detect vital parameters.

Bringing a drug to market is long and difficult. Studies estimate that the clinical trial process lasts 9 years and costs $1.3B on average. Clinical trials are conducted in multiple phases, with cost and complexity increasing from Phase I to Phase III. Despite the time and capital invested in trials, only 1 in 10 drugs that enter Phase I of a clinical trial will be approved by the FDA.
There is Large medical need to evaluate to treat the physical deterioration of physical status. A growing number of patients with mobility impairments lacks accurate tools to diagnose, monitor expensive evolutive diseases and intervene efficiently.

Gait is the simplest and most actionable biomarker to monitor multiple diseases but vastly underutilized as a biomarker or outcome measure because gait analysis is often not high quality when assessed in the clinic.Clinical gait tests, today, are used to identify mobility disorders, measure the efficacy of a therapeutic treatment. This is done in a controlled setting at sites. However, the technologies or design used present strong limitations. Episodic assessments, sometimes observational, don't generate sufficient sensitive data to demonstrate subtle changes.

The FeetMe solution allows the collection of validated gait data at site with the Insoles, and in the same accurate way in the patients daily life allowing continuous recording of gait data.

In this talk, Anders Strömberg, Director, Head of Wearable Platform Division, Sony Network Communications Europe, will discuss the issue of trust in IoT devices for remote monitoring, the challenges and some possible solutions.
Care providers need to monitor the wellbeing of their patients. That means staying connected with them wherever they are, whatever they’re doing. Most of today’s remote monitoring applications require pairing with cell phones or smartwatches, using standard LTE connectivity.
Healthcare providers are continuously seeking to increase the quantity and quality of information available, and to offer end-users more practical, timely insights. How can they do this while also providing solutions that are as easy for all kinds of end-users to handle?
The answer lies in the convergence of new IoT, telecommunications and AI technologies which enable access to rich data and allow service providers to develop new solutions; solutions that, for example, improve adherence to prescriptions, enable early detection of conditions like diabetes and boost the users’ general health and wellbeing.
Both service providers and end users show a high level of acceptance and willingness to adopt these new technologies in the pursuit of better health and health services. However, there are some serious trust issues when it comes to IoT. Although the risks are not new, concerns have risen to a new level because of the vast number of IoT devices deployed in the field and the way in which they are being used.
Against this backdrop, Strömberg will discuss the balancing act required to bring trust and quality of service together to enable the future of healthcare and put forward some ideas about how to provide access to more, better and diverse data that enables greater insights and tailored services.

Ensuring health and wellness is crucial for quality of life and longevity. Join us in a discussion how wearable technology and sensors are being created to monitor and report health throughout the human life cycle. Facilitating the human story of health and wellness from womb to late adulthood.

Ensuring health and wellness is crucial for quality of life and longevity. Join us in a discussion how wearable technology and sensors are being created to monitor and report health throughout the human life cycle. Facilitating the human story of health and wellness from womb to late adulthood.

Join us in the Spatial Chat lounge and network with fellow members and speakers. This is the ultimate in-person virtual experience giving you the opportunity not only to see but also chat with colleagues and new business contacts. Previous attendees have said:

"The networking lounge functionality is fantastic! For me, the best I've seen so far in virtual events, the closest you can get to a real feeling." and

"I really loved networking lounge you have! Never seen anything like it".

Grab and drink and join us, we look forward to meeting you there.

Accurate measurement of actual blood glucose levels is the base for effective diabetes management. This presentation will provide a snap-shot of the latest trends in glucose testing including continuous glucose monitoring (CGM) and emerging non-invasive methodologies that receive a lot of attention. We will also talk about the role of artificial intelligence (AI) and machine learning (ML) in this context, their potential but also some of the realities associated with AI/ML. Last but not least we will discuss how freely available data generated by all these innovative solutions creates value and evaluate the status of interoperability in diabetes care.

Smart Healthcare demands smart medical devices.
Wearable skin patches allow for comprehensive patient monitoring at medical grade accuracy, improving patient care to become more individualized and connected. Printed Electronics technology is a key enabler to smart health patches - allowing the creation of thin, flexible and lightweight sensing components and full solutions that increase the comfort of wear while allowing long-term vital sight monitoring.
Throughout this presentation Henkel Printed Electronics and Accensors will showcase latest printed electronic materials and sensing technologies to shape the next generation of smart health patches.

Smart Healthcare demands smart medical devices.
Wearable skin patches allow for comprehensive patient monitoring at medical grade accuracy, improving patient care to become more individualized and connected. Printed Electronics technology is a key enabler to smart health patches - allowing the creation of thin, flexible and lightweight sensing components and full solutions that increase the comfort of wear while allowing long-term vital sight monitoring.
Throughout this presentation Henkel Printed Electronics and Accensors will showcase latest printed electronic materials and sensing technologies to shape the next generation of smart health patches.

​

Neteera has designed and developed a contactless vital-signs monitoring product capable of detecting a variety of physiological parameters (Hear Rate, Hear Rate Variability, Respiration Rate, Respiration Depth, Inhale/Exhale ratio, Sleep Apnea, etc.), based on an on-chip sub-THz (116-123 GHz) micro-radar and advanced signal processing and AI algorithms. The Vital Sign parameters are monitored continuously and presented in real time on a monitor and/or stored in the cloud for offline analysis. The Product is targeted to both Remote Patient Monitoring (RPM) at home, Elderly care monitoring, Chronic diseases patients, relevant Hospital wards, etc.
Neteera’s novel micro radar-based solution enables measuring only the micro-motions of the skin (BCG-Ballistocardiograph) remotely, in real-time, non-invasive, and non-contact manner, through non-metallic materials such as furniture and clothing at a high resolution.
Neteera 130H product is based on the following key elements:
1. High-frequency (116-123 GHz), micro-radar on chip (with an on-package antenna).
2. Vital sign monitor algorithms, based on proprietary signal processing algorithms, that are designed to track the relevant vital signs metrics.
3. Cloud Cluster for data collection (including raw, processed, reference) and analysis.

This presentation will provide insights in how Quad Industries uses printed electronics as a platform technology to create wearable sensors and skin patches.
Printed circuit foils have been used for many years inside, amongst others, membrane switches and capacitive touch sensors, but one of the biggest opportunities in the field of printed electronics, lies in newly emerging applications, such as wearable health.
Quad Industries is a leading innovator in this field, and by means of S2S and R2R screen-printing techniques, the company integrates smart functionality on a wide range of materials, such as flexible and stretchable films.
This presentation highlights some of the recent developments in the development and manufacturing of electronic skin patches.

Join us in the Spatial Chat lounge and network with fellow members and speakers. This is the ultimate in-person virtual experience giving you the opportunity not only to see but also chat with colleagues and new business contacts. Previous attendees have said:

"The networking lounge functionality is fantastic! For me, the best I've seen so far in virtual events, the closest you can get to a real feeling." and

"I really loved networking lounge you have! Never seen anything like it".

Grab and drink and join us, we look forward to meeting you there.

​

The market share of the e-textile industry has seen an upward trend over the years. Rising awareness and the limitless possibilities to utilize the comfort and flexibility of textiles, combined with the intelligence of electronics has led to tremendous opportunities in the development and manufacture of e-textile and wearable products across various industry segments. The pandemic times have called for and accelerated the need for remote monitoring and opened new vistas of opportunities. With more investment by existing and emerging players in the research and development of such products, it is imperative for businesses to understand and clearly specify the e-textile product requirements. Each product being so unique in nature and function, makes it more critical to address their requirements in a comprehensive manner. This presentation will cover the key aspects to consider while specifying an e-textile product.

Neural implants aim at restoring lost or impaired functions of the nervous system by electrical stimulation or recording of the brain. Current neural implants suffer from a mechanical mismatch compared to the soft host tissue, as they constrain mechanically the physiological motion of the central nervous system. This mismatch causes poor electrode-tissue contact, leading to unspecific stimulation or recording, as well as chronic scarring. At Neurosoft Bioelectronics, we overcome these fundamental limitations by developing soft neural electrodes, using more compliant materials, that seamlessly interface with the brain, promoting the long-term bio-integration of the devices and reducing surgical risks.